McMaster A, Chambers T, Meng Q-J, Grundy S, Loudon A S I, Donn R, Ray D W
Centre for Molecular Medicine, ARC/EU, School of Medicine, Faculty of Medical and Human Sciences Faculty of Life Sciences, University of Manchester, Stopford Building, Manchester M13 9PT, UK.
J Endocrinol. 2008 May;197(2):205-11. doi: 10.1677/JOE-07-0639.
There is increasing evidence that temporal factors are important in allowing cells to gain additional information from external factors, such as hormones and cytokines. We sought to discover how cell responses to glucocorticoids develop over time, and how the response kinetics vary according to ligand structure and concentration, and hence have developed a continuous gene transcription measurement system, based on an interleukin-6 (IL-6) luciferase reporter gene. We measured the time to maximal response, maximal response and integrated response, and have compared these results with a conventional, end point glucocorticoid bioassay. We studied natural glucocorticoids (corticosterone and cortisol), synthetic glucocorticoids (dexamethasone) and glucocorticoid precursors with weak, or absent bioactivity. We found a close correlation between half maximal effective concentration (EC50) for maximal response, and for integrated response, but with consistently higher EC50 for the latter. There was no relation between the concentration of ligand and the time to maximal response. A comparison between conventional end point assays and real-time measurement showed similar effects for dexamethasone and hydrocortisone, with a less effective inhibition of IL-6 seen with corticosterone. We profiled the activity of precursor steroids, and found pregnenolone, progesterone, 21-hydroxyprogesterone and 17-hydroxyprogesterone all to be ineffective in the real-time assay, but in contrast, progesterone and 21-hydroxyprogesterone showed an IL-6 inhibitory activity in the end point assay. Taken together, our data show how ligand concentration can alter the amplitude of glucocorticoid response, and also that a comparison between real-time and end point assays reveals an unexpected diversity of the function of glucocorticoid precursor steroids, with implications for human disorders associated with their overproduction.
越来越多的证据表明,时间因素对于细胞从诸如激素和细胞因子等外部因素中获取额外信息至关重要。我们试图探究细胞对糖皮质激素的反应如何随时间发展,以及反应动力学如何根据配体结构和浓度而变化,因此基于白细胞介素 - 6(IL - 6)荧光素酶报告基因开发了一种连续基因转录测量系统。我们测量了达到最大反应的时间、最大反应和综合反应,并将这些结果与传统的终点糖皮质激素生物测定法进行了比较。我们研究了天然糖皮质激素(皮质酮和皮质醇)、合成糖皮质激素(地塞米松)以及生物活性弱或无生物活性的糖皮质激素前体。我们发现最大反应的半数最大有效浓度(EC50)与综合反应的EC50之间存在密切相关性,但后者的EC50始终更高。配体浓度与达到最大反应的时间之间没有关系。传统终点测定法与实时测量法的比较表明,地塞米松和氢化可的松的效果相似,而皮质酮对IL - 6的抑制作用较弱。我们分析了前体类固醇的活性,发现孕烯醇酮、孕酮、21 - 羟孕酮和17 - 羟孕酮在实时测定中均无效,但相比之下,孕酮和21 - 羟孕酮在终点测定中显示出IL - 6抑制活性。综上所述,我们的数据表明配体浓度如何改变糖皮质激素反应的幅度,并且实时测定法与终点测定法之间的比较揭示了糖皮质激素前体类固醇功能的意外多样性,这对与其过量产生相关的人类疾病具有启示意义。